Singh C - Search Results

1

Zebrafish an experimental model of Huntington's disease: molecular aspects, therapeutic targets and current challenges.

Kumar V, Singh C, Singh A. Kumar V, et al. Among authors: singh c, singh a. Mol Biol Rep. 2021 Dec;48(12):8181-8194. doi: 10.1007/s11033-021-06787-y. Epub 2021 Oct 19. Mol Biol Rep. 2021. PMID: 34665402 Review.

2

Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.

Rai SN, Singh C, Singh A, Singh MP, Singh BK. Rai SN, et al. Among authors: singh bk, singh c, singh a, singh mp. Mol Neurobiol. 2020 Jul;57(7):3075-3088. doi: 10.1007/s12035-020-01945-y. Epub 2020 May 27. Mol Neurobiol. 2020. PMID: 32462551 Review.

3

Classification of three prognostically different groups of Head and Neck Cancer patients based on their metabolic response to induction chemotherapy (IC-1).

Singh A, Singh CA, Sikka K. Singh A, et al. Among authors: singh ca. Oral Oncol. 2020 Dec;111:104936. doi: 10.1016/j.oraloncology.2020.104936. Epub 2020 Aug 22. Oral Oncol. 2020. PMID: 32839083 No abstract available.

4

Importance of Zebrafish as an Efficient Research Model for the Screening of Novel Therapeutics in Neurological Disorders.

Saluja D, Jhanji R, Kaushal S, Verma B, Sharma N, Singh R, Agrawal S, Yadav M, Kumar A, Singh C, Singh A. Saluja D, et al. Among authors: singh c, singh r, singh a. CNS Neurol Disord Drug Targets. 2021;20(2):145-157. doi: 10.2174/1871527319666201207211927. CNS Neurol Disord Drug Targets. 2021. PMID: 33290204

5

Withdrawal Notice: Involvement of the Gut-brain Axis in Neurological Disorders.

Kaushal S, Singh C, Singh A. Kaushal S, et al. Among authors: singh c, singh a. CNS Neurol Disord Drug Targets. 2021 Mar 10. doi: 10.2174/1871527320666210310141015. Online ahead of print. CNS Neurol Disord Drug Targets. 2021. PMID: 33745425

6

Coenzyme Q10 a mitochondrial restorer for various brain disorders.

Pradhan N, Singh C, Singh A. Pradhan N, et al. Among authors: singh c, singh a. Naunyn Schmiedebergs Arch Pharmacol. 2021 Nov;394(11):2197-2222. doi: 10.1007/s00210-021-02161-8. Epub 2021 Oct 1. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 34596729 Review.

7

Crosstalk between anticancer drugs and mitochondrial functions.

Sahu K, Langeh U, Singh C, Singh A. Sahu K, et al. Among authors: singh c, singh a. Curr Res Pharmacol Drug Discov. 2021 Aug 19;2:100047. doi: 10.1016/j.crphar.2021.100047. eCollection 2021. Curr Res Pharmacol Drug Discov. 2021. PMID: 34909674 Free PMC article. Review.

8

Lipopolysaccharide induced altered signaling pathways in various neurological disorders.

Singh S, Sahu K, Singh C, Singh A. Singh S, et al. Among authors: singh c, singh a. Naunyn Schmiedebergs Arch Pharmacol. 2022 Mar;395(3):285-294. doi: 10.1007/s00210-021-02198-9. Epub 2022 Jan 6. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 34989812 Review.

9

Quercetin ameliorates lipopolysaccharide-induced neuroinflammation and oxidative stress in adult zebrafish.

Singh S, Sahu K, Kapil L, Singh C, Singh A. Singh S, et al. Among authors: singh c, singh a. Mol Biol Rep. 2022 Apr;49(4):3247-3258. doi: 10.1007/s11033-022-07161-2. Epub 2022 Jan 30. Mol Biol Rep. 2022. PMID: 35094209

10

Inhalation potential of N-Acetylcysteine loaded PLGA nanoparticles for the management of tuberculosis: In vitro lung deposition and efficacy studies.

Puri V, Chaudhary KR, Singh A, Singh C. Puri V, et al. Among authors: singh c, singh a. Curr Res Pharmacol Drug Discov. 2022 Jan 18;3:100084. doi: 10.1016/j.crphar.2022.100084. eCollection 2022. Curr Res Pharmacol Drug Discov. 2022. PMID: 35112077 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,736 results

Search Page